TIRBANIBULIN (Klisyri®)

Clinical Indication

Grade 1 Actinic Keratoses for the face and scalp

Comments

Single treatment course only – not to be repeated.

Date of classification

November 2023

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.